Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu; Huihong Xu; Xihui Ying; Dengke Zhang; Linqiang Lai; Linyou Wang; Jianfei Tu; Jiansong Ji

doi:10.12659/MSM.923263

15 July 2020 : Clinical Research

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu^1ABC*, Huihong Xu^2DE, Xihui Ying^1EFG, Dengke Zhang^1CD, Linqiang Lai^1BC, Linyou Wang^3EF, Jianfei Tu^1CFG, Jiansong Ji^1BDG

DOI: 10.12659/MSM.923263

Med Sci Monit 2020; 26:e923263

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 MRI of the hepatocellular carcinoma 1 months after TACE+RFA (A, C: MRI of hepatocellular carcinoma 1 moth after TACE+RFA; B, D: MRI of hepatocellular carcinoma 6 moth after TACE+RFA).

Back to the Article

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Your Privacy